Remove 2005 Remove Leads Remove Side effects
article thumbnail

Targeting tumours with novel radiopharmaceuticals

European Pharmaceutical Review

Can you share an update on the clinical trial for your lead candidate? One aspect that is extremely promising about radiopharmaceutical therapeutics is that they do not give a patient the side effects that are commonly experienced with chemotherapy. Barrett at the Center for Gamma Ray Imaging.

article thumbnail

Gulf War Illness: How can disease modelling aid the search for a cure?

pharmaphorum

Not only does the appearance of a common symptom – such as a fever, for example – lead to potential misdiagnoses, but it can also lead to clinicians choosing ineffective therapies that treat symptoms, rather than the true cause of a disease. Tinker, tailor, soldier, therapy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

article thumbnail

Nanotechnology: A Massive Impact at the Molecular Level

Celeritas

They only partially impact the target areas and have damaging side effects in adjacent regions. Gold nanowires further positively impact key organ transplant functions – synapse formation and stem cell differentiation – all without using growth factors, which cause negative side effects. 16 August 2005).

article thumbnail

Direct to Patient Healthcare

Healthcare Success

Tune in to our latest podcast as Lee Aase, founder of HELPCare, LLC, shares how he transitioned from his pioneering social media work at Mayo Clinic to lead an innovative membership-based direct-to-patient healthcare business. Struggling with burnout while maintaining high-quality healthcare services that patients love? But let's get back to.

article thumbnail

Ep. 001 – John Mack Podcast Transcript

Pharma Marketing Network

So that was 2005. But you’d have to have one click to the side effects. John Mack (PG): But the industry evolved from there and they have the side effects on the same page. Who wants to deal with facts? RJ Lewis (EHS): Today, not many people apparently. It’s a blog. You were on Twitter very early.

Media 52